Concepedia

Publication | Open Access

Poor efficacy of anti‐programmed cell death‐1/ligand 1 monotherapy for non‐small cell lung cancer patients with active brain metastases

16

Citations

21

References

2020

Year

Abstract

Further studies on immunotherapy are needed for patients with active BMs.

References

YearCitations

Page 1